News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
Side-effects
HAART may cause oxidant stress says US study

An American study to be published in the December 15th edition of Clinical Infectious Diseases (now available on-line) found that HIV-positive individuals treated with HAART

Published
03 December 2003
By
Michael Carter
Side-effects
HAART patients at greater risk of severe side-effects than AIDS

HIV-positive individuals who take HAART are more likely to experience a serious or life-threatening treatment side-effect than develop an AIDS-defining condition, according to a US

Published
02 December 2003
By
Michael Carter
HIV treatment
WHO unveils plans to treat 3 million by 2005

The World Health Organisation has published details of its plan to bring antiretroviral treatment to 3 million people living with HIV by the end of

Published
01 December 2003
By
Keith Alcorn
HIV treatment
Community mobilisation key to success of 3 x 5

The WHO 3 x 5 plan envisages that community-based organisations, including groups of people living with HIV, will play a key role in scaling up

Published
01 December 2003
By
Keith Alcorn
HIV treatment
d4T/3TC/nevirapine will be preferred option for 3 x 5

International experts have agreed that a triple combination of d4T (stavudine), 3TC (lamivudine) and nevirapine is likely to be the best option for swift implementation

Published
01 December 2003
By
Keith Alcorn
HIV treatment
India to begin free HIV treatment programme, will treat 100,000 within a year

The Indian government will provide free antiretroviral treatment through government hospitals starting from April 2004, Health Minister Sushma Swaraj announced today. The Indian government plans

Published
30 November 2003
By
Keith Alcorn
HIV treatment
HIV testing in Africa: will VCT for all do more than ABC approach?

Two contrasting viewpoints on voluntary testing and counselling for HIV in developing countries are put forward this week in The Lancet. Whilst Dr Kevin De

Published
28 November 2003
By
Keith Alcorn
New and experimental HIV treatments
Tipranavir now available for emergency use in UK

Tipranavir, a new protease inhibitor under development by Boehringer-Ingelheim, is to be made available to any person with HIV in the UK who has a

Published
27 November 2003
By
Keith Alcorn
Changing treatment
Gastrointestinal side-effects lead one in eight to change HAART regimen in first year of treatment

Over 50% of patients taking anti-HIV treatments for the first time will change or stop taking their drugs in the first year of therapy, often

Published
27 November 2003
By
Michael Carter
Treatment simplification strategies
Kaletra monotherapy: unorthodox but effective regimen challenges the rules

Nine years after the treatment of HIV with a single drug was discredited in the Delta study, monotherapy resurfaced this week at the 43rd Interscience

Published
19 September 2003
By
Keith Alcorn
← Prev1...504505506507508Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.